115 related articles for article (PubMed ID: 25967708)
1. Relationship between CD4+CD25+ Treg and expression of HIF-1α and Ki-67 in NSCLC patients.
He LY; Li L; Guo ML; Zhang Y; Zhang HZ
Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1351-5. PubMed ID: 25967708
[TBL] [Abstract][Full Text] [Related]
2. Elevated Circulating CD4
Hu X; Gu Y; Zhao S; Hua S; Jiang Y
Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076
[No Abstract] [Full Text] [Related]
3. Low-dose splenic radiation inhibits liver tumor development of rats through functional changes in CD4+CD25+Treg cells.
Wang B; Li B; Dai Z; Ren S; Bai M; Wang Z; Li Z; Lin S; Wang Z; Huang N; Yang P; Liu M; Min W; Ma H
Int J Biochem Cell Biol; 2014 Oct; 55():98-108. PubMed ID: 25168696
[TBL] [Abstract][Full Text] [Related]
4. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
[TBL] [Abstract][Full Text] [Related]
5. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
7. Function and regulation of LAG3 on CD4
Ma QY; Huang DY; Zhang HJ; Wang S; Chen XF
Exp Cell Res; 2017 Nov; 360(2):358-364. PubMed ID: 28935468
[TBL] [Abstract][Full Text] [Related]
8. Effect of HIF1α on Foxp3 expression in CD4+ CD25- T lymphocytes.
Wu J; Cui H; Zhu Z; Wang L; Li H; Wang D
Microbiol Immunol; 2014 Jul; 58(7):409-15. PubMed ID: 24931519
[TBL] [Abstract][Full Text] [Related]
9. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Pircher A; Gamerith G; Amann A; Reinold S; Popper H; Gächter A; Pall G; Wöll E; Jamnig H; Gastl G; Wolf AM; Hilbe W; Wolf D
Lung Cancer; 2014 Jul; 85(1):81-7. PubMed ID: 24780112
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha.
Ben-Shoshan J; Maysel-Auslender S; Mor A; Keren G; George J
Eur J Immunol; 2008 Sep; 38(9):2412-8. PubMed ID: 18792019
[TBL] [Abstract][Full Text] [Related]
12. [Expression of hypoxia inducible factor-1alpha and relationship thereof to apoptosis related protein in non-small cell lung cancer].
Chen YF; Yang HP; Hu JL; Zhou XD; Xiong W; Dai XT; Li XJ
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):921-3. PubMed ID: 17650407
[TBL] [Abstract][Full Text] [Related]
13. CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients.
Ju S; Qiu H; Zhou X; Zhu B; Lv X; Huang X; Li J; Zhang Y; Liu L; Ge Y; Johnson DE; Ju S; Shu Y
Cell Cycle; 2009 Aug; 8(16):2578-85. PubMed ID: 19597336
[TBL] [Abstract][Full Text] [Related]
14. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.
Kataoka H; Yasuda S; Fukaya S; Oku K; Horita T; Atsumi T; Koike T
Mod Rheumatol; 2015 Jan; 25(1):90-5. PubMed ID: 24716598
[TBL] [Abstract][Full Text] [Related]
16. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
18. HIF-2α not HIF-1α overexpression confers poor prognosis in non-small cell lung cancer.
Gao ZJ; Wang Y; Yuan WD; Yuan JQ; Yuan K
Tumour Biol; 2017 Jun; 39(6):1010428317709637. PubMed ID: 28653893
[TBL] [Abstract][Full Text] [Related]
19. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
[TBL] [Abstract][Full Text] [Related]
20. [Correlations of 99 Tc m-HL91 SPECT hypoxia imaging with HIF-1alpha and VEGF expression in non-small cell lung cancer].
Li L; Hu M; Yu JM; Yang GR; Guo HB; Gao Y
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):669-73. PubMed ID: 20021862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]